{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:05:02Z","timestamp":1793851502726,"version":"4.6.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370131"],"award-info":[{"award-number":["82370131"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370132"],"award-info":[{"award-number":["82370132"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300152"],"award-info":[{"award-number":["82300152"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.thromres.2025.109475","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T01:16:59Z","timestamp":1757467019000},"page":"109475","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Inhibiting mTORC1 pathway by rapamycin restores the balance of CD8+ T cell subsets and reduces CD8+ T cell-mediated platelet destruction in immune thrombocytopenia"],"prefix":"10.1016","volume":"254","author":[{"given":"Xiaofei","family":"Ni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianshu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouqing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihua","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.thromres.2025.109475_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103677","article-title":"Autoimmune effector mechanisms associated with a defective immunosuppressive axis in immune thrombocytopenia (ITP)","volume":"23","author":"Li","year":"2024","journal-title":"Autoimmun. Rev."},{"issue":"20","key":"10.1016\/j.thromres.2025.109475_bb0010","first-page":"2417","article-title":"The role of CD8+ T-cell clones in immune thrombocytopenia","volume":"141","author":"Malik","year":"2023","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.thromres.2025.109475_bb0015","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/ejh.13705","article-title":"T cell-mediated autoimmunity in immune thrombocytopenia","volume":"108","author":"Vrbensky","year":"2022","journal-title":"Eur. J. Haematol."},{"issue":"5","key":"10.1016\/j.thromres.2025.109475_bb0020","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1111\/bjh.16334","article-title":"Increased cytotoxic potential of CD8(+) T cells in immune thrombocytopenia","volume":"188","author":"Vrbensky","year":"2020","journal-title":"Br. J. Haematol."},{"issue":"9","key":"10.1016\/j.thromres.2025.109475_bb0025","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/nm921","article-title":"T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura","volume":"9","author":"Olsson","year":"2003","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.thromres.2025.109475_bb0030","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3324\/haematol.12889.","article-title":"Increased cytotoxic T-lymphocyte-mediated cytotoxicity predominant in patients with idiopathic thrombocytopenic purpura without platelet autoantibodies","volume":"93","author":"Zhao","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2025.109475_bb0035","article-title":"CD8(+) T cells induce platelet clearance in the liver via platelet desialylation in immune thrombocytopenia","volume":"6","author":"Qiu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.thromres.2025.109475_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.630693","article-title":"Low-dose decitabine inhibits cytotoxic T lymphocytes-mediated platelet destruction via modulating PD-1 methylation in immune thrombocytopenia","volume":"12","author":"Han","year":"2021","journal-title":"Front. Immunol."},{"issue":"22","key":"10.1016\/j.thromres.2025.109475_bb0045","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1182\/blood-2014-06-580084","article-title":"Interleukin 27 inhibits cytotoxic T-lymphocyte-mediated platelet destruction in primary immune thrombocytopenia","volume":"124","author":"Zhou","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.thromres.2025.109475_bb0050","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1365-2141.2007.06737.x","article-title":"CD8+ T cells suppress autologous megakaryocyte apoptosis in idiopathic thrombocytopenic purpura","volume":"139","author":"Li","year":"2007","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.thromres.2025.109475_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/genes12050728","article-title":"MTOR Signaling and Metabolism in Early T Cell Development","volume":"12","author":"Werlen","year":"2021","journal-title":"Genes (Basel)"},{"issue":"1","key":"10.1016\/j.thromres.2025.109475_bb0060","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-024-05470-2","article-title":"Ship-1 regulates the differentiation and function of Tregs via inhibiting mTORC1 activity","volume":"82","author":"Du","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"issue":"79","key":"10.1016\/j.thromres.2025.109475_bb0065","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abq0178","article-title":"Elevated transferrin receptor impairs T cell metabolism and function in systemic lupus erythematosus","volume":"8","author":"Voss","year":"2023","journal-title":"Sci. Immunol."},{"issue":"4","key":"10.1016\/j.thromres.2025.109475_bb0070","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.4049\/jimmunol.1400769","article-title":"Mammalian target of rapamycin complex 1 orchestrates invariant NKT cell differentiation and effector function","volume":"193","author":"Zhang","year":"2014","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.thromres.2025.109475_bb0075","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1172\/JCI77746","article-title":"mTORC1 and mTORC2 selectively regulate CD8(+) T cell differentiation","volume":"125","author":"Pollizzi","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"7251","key":"10.1016\/j.thromres.2025.109475_bb0080","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08155","article-title":"mTOR regulates memory CD8 T-cell differentiation","volume":"460","author":"Araki","year":"2009","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.thromres.2025.109475_bb0085","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.immuni.2011.04.006","article-title":"A central role for mTOR kinase in homeostatic proliferation induced CD8+ T cell memory and tumor immunity","volume":"34","author":"Li","year":"2011","journal-title":"Immunity"},{"issue":"15","key":"10.1016\/j.thromres.2025.109475_bb0090","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.4161\/cc.9.15.12359","article-title":"Fine-tuning CD8(+) T cell functional responses: mTOR acts as a rheostat for regulating CD8(+) T cell proliferation, survival and differentiation?","volume":"9","author":"Rao","year":"2010","journal-title":"Cell Cycle"},{"issue":"3","key":"10.1016\/j.thromres.2025.109475_bb0095","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.cmet.2024.01.005","article-title":"Tumor-secreted FGF21 acts as an immune suppressor by rewiring cholesterol metabolism of CD8(+)T cells","volume":"36","author":"Hu","year":"2024","journal-title":"Cell Metab."},{"issue":"9","key":"10.1016\/j.thromres.2025.109475_bb0100","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1038\/s41418-021-00775-2","article-title":"CCL2 regulation of MST1-mTOR-STAT1 signaling axis controls BCR signaling and B-cell differentiation","volume":"28","author":"Yang","year":"2021","journal-title":"Cell Death Differ."},{"issue":"2","key":"10.1016\/j.thromres.2025.109475_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23020967","article-title":"Abnormal mTOR activity in pediatric autoimmune neuropsychiatric and MIA-associated autism spectrum disorders","volume":"23","author":"Trifonova","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.thromres.2025.109475_bb0110","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/rheumatology\/key038","article-title":"Activation of mechanistic target of rapamycin complex 1: the common link between rheumatoid arthritis and diabetes mellitus","volume":"58","author":"De Vita","year":"2019","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.thromres.2025.109475_bb0115","doi-asserted-by":"crossref","first-page":"6915","DOI":"10.1038\/s41467-022-34480-6","article-title":"mTORC1 links pathology in experimental models of Still\u2019s disease and macrophage activation syndrome","volume":"13","author":"Huang","year":"2022","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.thromres.2025.109475_bb0120","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11926-016-0622-8","article-title":"activation of the mechanistic target of rapamycin in SLE: explosion of evidence in the last five years","volume":"18","author":"Oaks","year":"2016","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.thromres.2025.109475_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103125","article-title":"Rapamycin nanoparticles increase the therapeutic window of engineered interleukin-2 and drive expansion of antigen-specific regulatory T cells for protection against autoimmune disease","volume":"140","author":"Kishimoto","year":"2023","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.thromres.2025.109475_bb0130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neulet.2019.04.035","article-title":"Rapamycin relieves inflammation of experimental autoimmune encephalomyelitis by altering the balance of Treg\/Th17 in a mouse model","volume":"705","author":"Li","year":"2019","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.thromres.2025.109475_bb0135","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000617","article-title":"Sirolimus versus tacrolimus for systemic lupus erythematosus treatment: results from a real-world CSTAR cohort study","volume":"9","author":"Jiang","year":"2022","journal-title":"Lupus Sci. Med."},{"issue":"4","key":"10.1016\/j.thromres.2025.109475_bb0140","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/MBC.0000000000001303","article-title":"Clinical study reveals the efficacy of sirolimus in treating primary immune thrombocytopenia: findings from a single-center study","volume":"35","author":"Feng","year":"2024","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.thromres.2025.109475_bb0145","article-title":"Sirolimus as rescue therapy for refractory\/relapsed immune thrombocytopenia: results of a single-center, prospective, single-arm study","volume":"7","author":"Feng","year":"2020","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.thromres.2025.109475_bb0150","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.exphem.2020.08.001","article-title":"Sirolimus is effective for primary relapsed\/refractory autoimmune cytopenia: a multicenter study","volume":"89","author":"Li","year":"2020","journal-title":"Exp. Hematol."},{"issue":"1","key":"10.1016\/j.thromres.2025.109475_bb0155","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1080\/16078454.2022.2151230","article-title":"Progress on the efficacy and potential mechanisms of rapamycin in the treatment of immune thrombocytopenia","volume":"27","author":"Wang","year":"2022","journal-title":"Hematology"},{"issue":"1","key":"10.1016\/j.thromres.2025.109475_bb0160","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/s13046-018-1002-1","article-title":"Classification of triple-negative breast cancers based on Immunogenomic profiling","volume":"37","author":"He","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"21","key":"10.1016\/j.thromres.2025.109475_bb0165","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1182\/blood-2017-03-754119","article-title":"Clinical updates in adult immune thrombocytopenia","volume":"129","author":"Lambert","year":"2017","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.thromres.2025.109475_bb0170","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1182\/blood-2015-10-674531","article-title":"High-dose dexamethasone corrects impaired myeloid-derived suppressor cell function via Ets1 in immune thrombocytopenia","volume":"127","author":"Hou","year":"2016","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.thromres.2025.109475_bb0175","doi-asserted-by":"crossref","first-page":"5362","DOI":"10.1182\/blood-2009-05-217513","article-title":"The effects of BAFF and BAFF-R-Fc fusion protein in immune thrombocytopenia","volume":"114","author":"Zhu","year":"2009","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.thromres.2025.109475_bb0180","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1182\/blood-2009-09-244772","article-title":"A murine model of severe immune thrombocytopenia is induced by antibody- and CD8+ T cell-mediated responses that are differentially sensitive to therapy","volume":"115","author":"Chow","year":"2010","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.thromres.2025.109475_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224276","article-title":"Dysregulated T helper type 1 (Th1) and Th17 responses in elderly hospitalised patients with infection and sepsis","volume":"14","author":"Coakley","year":"2019","journal-title":"PLoS One"},{"issue":"6754","key":"10.1016\/j.thromres.2025.109475_bb0190","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions","volume":"401","author":"Sallusto","year":"1999","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.thromres.2025.109475_bb0195","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nri3158","article-title":"Standardizing immunophenotyping for the human immunology project","volume":"12","author":"Maecker","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.thromres.2025.109475_bb0200","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1152\/physrev.00026.2020","article-title":"Regulation and metabolic functions of mTORC1 and mTORC2","volume":"101","author":"Szwed","year":"2021","journal-title":"Physiol. Rev."},{"issue":"9","key":"10.1016\/j.thromres.2025.109475_bb0205","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1007\/s00277-023-05348-6","article-title":"The mTORC1 pathway participate in hyper-function of B cells in immune thrombocytopenia","volume":"102","author":"Xiang","year":"2023","journal-title":"Ann. Hematol."},{"issue":"7","key":"10.1016\/j.thromres.2025.109475_bb0210","doi-asserted-by":"crossref","first-page":"134","DOI":"10.21037\/atm.2019.03.04","article-title":"Enhancing autophagy protects platelets in immune thrombocytopenia patients","volume":"7","author":"Wang","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.thromres.2025.109475_bb0215","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.critrevonc.2016.01.011","article-title":"Targeting autophagy as a potential therapeutic approach for immune thrombocytopenia therapy","volume":"100","author":"Shan","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"11","key":"10.1016\/j.thromres.2025.109475_bb0220","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a037796","article-title":"Area under immunosurveillance: dedicated roles of memory CD8 T-cell subsets","volume":"12","author":"Parga-Vidal","year":"2020","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.thromres.2025.109475_bb0225","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev-immunol-032712-095954","article-title":"Memory T cell subsets, migration patterns, and tissue residence","volume":"31","author":"Mueller","year":"2013","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.thromres.2025.109475_bb0230","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/bjh.14661","article-title":"Numerical and functional defects in CD8(+) CD28(\u2212) T-suppressor lymphocytes from patients with primary immune thrombocytopenia","volume":"178","author":"Li","year":"2017","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.thromres.2025.109475_bb0235","doi-asserted-by":"crossref","DOI":"10.1080\/16078454.2024.2304486","article-title":"Lymphocyte subpopulations: a potential predictor of a response in patients with immune thrombocytopenia","volume":"29","author":"Zibridova","year":"2024","journal-title":"Hematology"},{"issue":"14","key":"10.1016\/j.thromres.2025.109475_bb0240","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1182\/blood-2013-03-491415","article-title":"Preferential splenic CD8(+) T-cell activation in rituximab-nonresponder patients with immune thrombocytopenia","volume":"122","author":"Audia","year":"2013","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.thromres.2025.109475_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/cells10112973","article-title":"Harnessing CD8(+)CD28(\u2212) regulatory T cells as a tool to treat autoimmune disease","volume":"10","author":"Ceeraz","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.thromres.2025.109475_bb0250","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/548085","article-title":"Effects of rapamycin combined with low dose prednisone in patients with chronic immune thrombocytopenia","author":"Li","year":"2013","journal-title":"Clin. Dev. Immunol."},{"issue":"1","key":"10.1016\/j.thromres.2025.109475_bb0255","doi-asserted-by":"crossref","DOI":"10.1080\/09537104.2023.2277831","article-title":"Optimizing the therapeutic window of sirolimus by monitoring blood concentration for the treatment of immune thrombocytopenia","volume":"34","author":"Zhang","year":"2023","journal-title":"Platelets"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825002257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825002257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T09:38:52Z","timestamp":1762249132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384825002257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":51,"alternative-id":["S0049384825002257"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109475","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibiting mTORC1 pathway by rapamycin restores the balance of CD8+ T cell subsets and reduces CD8+ T cell-mediated platelet destruction in immune thrombocytopenia","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109475","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109475"}}